Back

Prospective validation of a unique pretest probability score for preoperative deep vein thrombosis.

28 August 2023 (09:15 - 09:45)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk assessment: imaging Imaging ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Yuki Hamamoto

Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima (Japan)

4 More presentations in this session

Presentation thumbnail
Artificial intelligence analysis applied to facial features for prediction of high-risk coronary atherosclerosis at cardiac CT: the LOMBROSO Trial
Doctor E. Conte (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Reference intervals for carotid artery intima-media thickness measurements in the multi-ethnic Asian population: relationship with cardiometabolic risk factors
Associate Professor R. Dalan (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Feature-based clustering of left ventricular strain curve for risk stratification in the general population
Mr E. Ntalianis (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Could a high epicardial adipose tissue volume increase the ability of the calcium score to discriminate cardiovascular events in an asymptomatic population?
Doctor M. Temtem (Funchal, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk assessment: imaging

The Event

Event poster

ESC Congress 2023

28 August 2023 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Application of DOAC Score for the risk-stratification of major bleeding in patients with venous thromboembolism on direct oral anticoagulants: insight from the COMMAND VTE Registry-2
thumbnail
Congress Presentation
A novel dynamic risk score to predict venous thromboembolism (VTE) recurrences after 3 months of anticoagulation in patients with incident VTE and without active cancer.
thumbnail
Congress Presentation
A novel dynamic risk score to predict Clinically Significant Bleeding (CSB) after 3 months of anticoagulation in patients with incident Venous ThromboEmbolism (VTE) and without active cancer.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources